image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

Reach - Plus products now over 30% of Digital

September 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RCH
  • Price:
  • 94p
Reach again showed its mettle in tough advertising conditions with first half revenues declining 2% to £297.4m. However, a 7% rise in operating costs - chiefly a 54% hike in newsprint to £38.8m alone – meant operating margins declined almost 7% to 15.9%, leading to a one third decline in operating profit to £47.2m and eps to 12p.Digital revenue growth slowed to 5.4% year on year in H1, with Q2 flat, driven by a significant proportion of “brand unsafe” content due to the Ukraine war and a deterioration in wider market yields as weaker macro conditions caused advertisers to cut back. However, this was partially offset by strong performance in its data driven Plus products, with yields up to 10x OMP, and which now represents over 30% ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author